Biogen Inc. - Jan 10, 2025 SCHEDULE 13D Report for Sage Therapeutics, Inc. Common Stock, par value $0.0001 per share (SAGE)

Filing Manager
BIOGEN INC.
Reporting Manager
BIOGEN INC.
Security
Sage Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
SAGE
Shares outstanding
61.2M shares
Disclosed Ownership
6.24M shares
Ownership
10.2%
Form type
SCHEDULE 13D
Date filed
1/10/2025, 05:34 PM
Date of event
Jan 10, 2025
SEC
View on sec.gov

Reporting Managers (2)